Metalloid transport by aquaglyceroporins: Consequences in the treatment of human diseases

14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Metalloids can severely harm human physiology in a toxicological sense if taken up from the environment in acute high doses or chronically. However, arsenic or antimony containing drugs are still being used as treatment and are often the sole regime for certain forms of cancer, mainly types of leukemia and diseases caused by parasites, such as sleeping sickness or leishmaniasis. In this chapter, we give an outline of the positive effects of arsenicals and antimonials against such diseases, we summarize data on uptake pathways through human and parasite aquaglyceroporins and we discuss the progress and options in the development of therapeutic aquaporin and aquaglyceroporin inhibitor compounds. © 2010 Landes Bioscience and Springer Science+Business Media.

Cite

CITATION STYLE

APA

Mukhopadhyay, R., & Beitz, E. (2010). Metalloid transport by aquaglyceroporins: Consequences in the treatment of human diseases. Advances in Experimental Medicine and Biology, 679, 57–69. https://doi.org/10.1007/978-1-4419-6315-4_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free